C12Y 302/01151
Xyloglucan-specific endo-beta-1,4-glucanase , i.e. endoxyloglucanase
Official title: Xyloglucan-specific endo-beta-1,4-glucanase (3.2.1.151), i.e. endoxyloglucanase
C12Y302/01151 (Xyloglucan-specific endo-beta-1,4-glucanase , i.e. endoxyloglucanase) appears on 14 US grants and 26 published applications in this corpus.
Search patents in C12Y- Granted patents
- 14
- Published applications
- 26
- Assignees
- 7
- Inventors
- 71
- Latest grant
- 9 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 3 | 1 |
| 2014 | 1 | 3 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fusion proteins, recombinant bacteria, and exosporium fragments for plant health9 Jul 2024US 12,031,164 B2Spogen Biotech Inc.
- Method for preparing xyloglucan-oligosaccharides4 Apr 2023US 11,618,913 B2Technische Universität München
- Polypeptides having protease activity and polynucleotides encoding same17 Nov 2020US 10,837,006 B2Novozymes A/S
- Structured liquid compositions16 Oct 2018US 10,100,269 B2The Procter & Gamble Company
- Variants of a family 44 xyloglucanase31 Jul 2018US 10,035,998 B2Novozymes A/S
- Cleaning compositions and uses thereof30 Jul 2026US 2026/0218089 A1Novozymes A/S
- Use of xyloglucanase for improvement of sustainability of detergents5 Jun 2025US 2025/0179393 A1Novozymes A/S
- Detergent compositions containing a xyloglucanase and a hueing dye8 May 2025US 2025/0145912 A1The Procter & Gamble Company
- Fusion proteins, recombinant bacteria, and exosporium fragments for plant health26 Dec 2024US 2024/0425840 A1Spogen Biotech Inc.
- Method for preparing xyloglucan-oligosaccharides21 Dec 2023US 2023/0407355 A1Technische Universität München
Most cited
By later US patents
- Structured liquid compositions13US 10,100,269 B2The Procter & Gamble Company · 2018
- Structured liquid compositions11US 9,534,191 B2The Procter & Gamble Company · 2017
- Family 44 xyloglucanases10US 6,815,192 B2Novozymes A/S · 2004
- Family 44 xyloglucanases7US 7,361,736 B2Novozymes A/S · 2008
- Fusion proteins, recombinant bacteria, and exosporium fragments for plant health4US 12,031,164 B2Spogen Biotech Inc. · 2024